Venous thromboembolism and cancer;Thrombose veineuse et cancer

Annales de Biologie Clinique

Volumn 58, Issue 6, 2000, Pages 675-682

  Gouin Thibaut, I ^a   Samama, M M ^a  

^a HÔPITAL CHARLES FOIX   (France)

Author keywords

Cancer; Venous thrombosis

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN DERIVATIVE;

CANCER LOCALIZATION; COLORECTAL CANCER; DISEASE ASSOCIATION; HUMAN; IDIOPATHIC DISEASE; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; OVARY CANCER; PANCREAS CANCER; PATHOPHYSIOLOGY; PROSTATE CANCER; REVIEW; THROMBOEMBOLISM; VEIN THROMBOSIS;

ADMINISTRATION, ORAL; AGED; ANTICOAGULANTS; ANTINEOPLASTIC AGENTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION TESTS; CATHETERIZATION; CLINICAL TRIALS; DISSEMINATED INTRAVASCULAR COAGULATION; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; HEPARIN; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; ODDS RATIO; RISK FACTORS; THROMBOEMBOLISM; THROMBOPHILIA; TIME FACTORS; VENOUS THROMBOSIS; WARFARIN;

EID: 0033663708     PISSN: 00033898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (37)

1. Venous thrombosis as first manifestation of cancer
2. Venous thromboembolism and cancer
3. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism
4. Deep vein thrombosis and the incidence of subsequent symptomatic cancer
5. Occult cancer in patients with deep venous thrombosis: A systematic approach
6. Occult cancer and venous thromboembolism
7. Clinical guidelines: Screening for prostate cancer. Clinical guideline: Part III
8. Testing for occult cancer in patients with idiopathic deep vein thrombosis: A decision analysis
9. Screening for occult malignancy in patients with idiopathic venous thromboembolism (Somit): Study design
10. Thrombotic complications of central venous catheters in cancer patients
11. Hypercoagulability in cancer
12. The thrombophilic state induced by therapeutic agents in the cancer patient
13. Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer
14. Human tumor procoagulants: Registry of the Subcommittee on Haemostasis and Malignancy of the Scientific and Standardization Committee, International Society on Thrombosis and Haemostasis
15. Tissue factor as a tumor procoagulant
16. A factor X activating cysteine protease from malignant tissue
17. Cancer procoagulant in acute non lymphoid leukemia: Relationship of enzyme detection to disease activity
18. The role of plasminogen activation system in cancer
19. Tumor cell u-PA as a cause of fibrinolytic bleeding in metastatic disease
20. Pathophysiology of the thrombophilic state in the cancer patient
21. Effect of warfarine on survival in carcinoma of the lung, colon, head and neck and prostate
22. Effect of mopidamol on survival in carcinoma of the lung and colon: Final report of Veterans Administration Cooperative study n°188
23. Prognostic impact of an activation of coagulation in lung cancer
24. Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery
25. Plasma D-dimer levels in operable breast cancer patients correlate with clinical stage and axillary lymph node status
26. Blood coagualtion and thrombosis in patient with ovarian malignancy
27. Prognostic significance of plasma D-dimer levels in patients with lung cancer
28. D-dimer a useful marker of disease stage in colorectal cancer surgery?
29. Coagulation abnormalities in malignancy: A review
30. Elevated TFPI in malignancy disease: Relation to cancer type and hypercoagulation
31. Prevention of venous thromboembolism
32. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2,500 Versus 5,000 anti-Xa IU in 2,070 patients
33. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients
34. Prevention of thrombotic disorders in cancer patients undergoing chemotherapy